title: Boostrix (GlaxoSmithKline).
abstract: GlaxoSmithKline plc has developed and launched Boostrix, a subunit vaccine for use in adolescents and adults as a booster immunization against diphtheria, tetanus and pertussis (DTPa) infections.
authors.affiliation: ID Biomedical Corp of Quebec, Canada. tjones@idbiomedical.com
authors.forename: Taff
authors.initials: T
authors.lastname: Jones
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000737:chemistry / Q000276:immunology* / Q000493:pharmacokinetics / Q000633:toxicity; D006801:Humans; D007117:Immunization, Secondary; D013329:Structure-Activity Relationship
chemical_list: C505143:Boostrix; D015721:Diphtheria-Tetanus-Pertussis Vaccine